跳至主要内容
临床试验/NCT03361280
NCT03361280已完成1 期

Beta-blocker Dialyzability in Maintenance Hemodialysis Patients

Lawson Health Research Institute0 个研究点目标入组 8 人开始时间: 2015年2月27日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
8
主要终点
Dialytic Clearance

研究概览

简要总结

Eight maintenance hemodialysis patients are given one of four beta blocker drugs (atenolol, bisoprolol, carvedilol, metoprolol) three hours prior to a hemodialysis session. Blood samples and spent dialysate are collected during dialysis. On separate dialysis sessions, patients received the other study drugs until they have taken each of the four study drugs. Dialytic clearance is calculated.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • at least 18 years of age, receiving hemodialysis three times per week for at least 90 days.

排除标准

  • gastrointestinal or liver disease, body mass index greater than 40 kg/m2, contraindications for receiving a beta blocker (treatment with contraindicated medications, prior adverse reaction, severe reactive airway disease, hemodynamic instability during dialysis).

研究组 & 干预措施

Atenolol

Experimental

Atenolol (50 mg) administered 3 hours prior to a hemodialysis session. Blood samples are collected a multiple times during dialysis and spent dialysate is collected at the end of the dialysis session.

干预措施: Beta blocker (Drug)

Bisoprolol

Experimental

Bisoprolol (5 mg) administered 3 hours prior to a hemodialysis session. Blood samples are collected a multiple times during dialysis and spent dialysate is collected at the end of the dialysis session.

干预措施: Beta blocker (Drug)

Metoprolol

Experimental

Metoprolol (50 mg) administered 3 hours prior to a hemodialysis session. Blood samples are collected a multiple times during dialysis and spent dialysate is collected at the end of the dialysis session.

干预措施: Beta blocker (Drug)

Carvedilol

Experimental

Carvedilol (6.25 mg) administered 3 hours prior to a hemodialysis session. Blood samples are collected a multiple times during dialysis and spent dialysate is collected at the end of the dialysis session.

干预措施: Beta blocker (Drug)

结局指标

主要结局

Dialytic Clearance

时间窗: Through study completion, average of one year.

Dialytic clearance calculated by the recovery clearance method

次要结局

  • Dialytic Clearance(Through study completion, average of one year.)

研究者

申办方类型
Other
责任方
Sponsor

相似试验